Adenosine enhances IL-10 secretion by human monocytes

Journal of Immunology

Volumn 156, Issue 11, 1996, Pages 4408-4414

  Le Moine, Olivier ^a   Stordeur, Patrick ^a   Schandené, Liliane ^a   Marchant, Arnaud ^a,c   De Groote, Donat ^b   Goldman, Michel ^a   Devière, Jacques ^a  

^a ERASME HOSPITAL   (Belgium)

^b Medgenix Research and Development   (Belgium)

^c FUND FOR SCIENTIFIC RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

2 CHLOROADENOSINE; ADENOSINE; DIPYRIDAMOLE; HYDROGEN PEROXIDE; INTERLEUKIN 10; THEOPHYLLINE; TUMOR NECROSIS FACTOR;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL CULTURE; CELL ISOLATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; ISCHEMIA; PEROXIDATION; PRIORITY JOURNAL; RECEPTOR BINDING; REOXYGENATION; REPERFUSION; STATISTICAL ANALYSIS; TISSUE INJURY;

ADENOSINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INFLAMMATION; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MONOCYTES; RECEPTORS, PURINERGIC P1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029933663     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Van Belle, H., F. Goossens, and J. Wynants. 1987. Formation and release of purine catabolites during hypoperfusion, anoxia and ischemia. Am. J. Physiol. 252:H886.
2. Matherne, G. P., J. P. Headrick, S. D. Coleman, and R. M. Berne. 1990. Interstitial transudate purines in normoxic and hypoxic immature and mature rabbit hearts. Pediatr. Res. 28:348.
3. - generation, respectively. J. Clin. Invest. 85:1150.
4. Cronstein, B. N., R. I. Levin, M. R. Philips, R. Hirschorn, S. B. Abramson, and G. Weissman. 1992. Neutrophil adherence to endothelium is enhanced via adenosine A1 receptors and inhibited via adenosine A2 receptors. J. Immunol. 148: 2201.
5. Felsh, A., K. Stöcker, and U. Borchard. 1995. Phorbol ester-stimulated adherence of neutrophils to endothelial cells is reduced by adenosine A2 receptor agonists. J. Immunol. 155:333.
6. Jurgensen, C. H., B. E. Huber, T. P. Zimmerman, and G. Wolberg. 1990. 3-Deazaadenosine inhibits leucocyte adhesion and ICAM-1 biosynthesis in tumor necrosis factor-stimulated human endothelial cells. J. Immunol. 144:653.
7. Grisham, M. B., L. A. Hernandez, and D. N. Granger. 1989. Adenosine inhibits ischemia-reperfusion-induced leukocyte adherence and extravasation. Am. J. Physiol. 257:H1334.
8. Sandhu, G. S., A. C. Burrier, and D. R. Janero. 1993. Adenosine deaminase inhibitors attenuate ischemic injury and preserve energy balance in isolated guinea pig heart. Am. J. Physiol. 265:H1249.
9. Cronstein, B. N., D. Naime, and E. Ostad. 1993. The antinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. J. Clin. Invest. 92:2675.
10. Asako, H., R. E. Wolf, and D. N. Granger. 1993. Leukocyte adherence in rat mesenteric veinules: effects of adenosine and methotrexate. Gastroenterology 104:31.
11. Parmely, M. J., W. W. Zou, C. K. Edwards, D. R. Borcherding, R. Silverstein, and D. C. Morrison. 1993. Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor necrosis factor-α production and protect mice against endotoxin challenge. J. Immunol. 151:389.
12. Reinstein, L. J., S. N. Lichtman, R. T. Currin, J. Wang, R. G. Thurman, and J. J. Lemasters. 1994. Suppression of lipopolysaccharide-stimulated release of tumor necrosis factor by adenosine: evidence for A2 receptors on rat Kupffer cells. Hepatology 19:1445.
13. Bouma, M. G., R. K. Stad, F. A. J. M. van den Wildenberg, and W. A. Buurman. 1994. Differential regulatory effects of adenosine on cytokine release by activated human monocytes. J. Immunol. 153:4159.
14. Prabhakar, U., D. P. Brooks, D. Lipshlitz, and K. M. Esser. 1995. Inhibition of LPS-induced TNF-α production in human monocytes by adenosine (A2) receptor selective agonists. Int. J. Immunopharmacol. 17:221.
15. Fong, Y., and S. F. Lowry. 1990. Tumor necrosis factor in the pathophysiology of infection and sepsis. Clin. Immunol. Immunopathol. 55:157.
16. Coletti, L. M., D. G. Remick, G. D. Burtch, S. L. Kunkel, R. M. Strieter, and D. A. Campbell, Jr. 1990. Role of tumor necrosis factor-α in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J. Clin. Invest. 85:1936.
17. Goto, M., Y. Takey, S. Kawano, S. Tsuji, H. Fukui, H. Fushimi, Y. Nishimura, T. Kashiwagi, H. Fusamoto, and T. Kamada. 1992. Tumor necrosis factor and endotoxin in the pathogenesis of liver and pulmonary injuries after orthotopic liver transplantation in the rat. Hepatology 16:487.
18. de Waal Malefyt, R., J. Abrams, B. Bennett, C. G. Figdor, and J. E. de Vries. 1991. Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174:1209.
19. Marchant, A., C. Bruyns, P. Vandenabeele, M. Ducarme, C. Gérard, A. Delvaux, D. De Groote, D. Abramowicz, T. Velu, and M. Goldman. 1994. Interleukin-10 controls interferon-γ and tumor necrosis factor production during experimental endotoxemia. Eur. J. Immunol. 24:1167.
20. Gérard, C., C. Bruyns, A. Marchant, D. Abramowicz, P. Vandenabeele, A. Delvaux, W. Fiers, M. Goldman, and T. Velu. 1993. Interleukin-10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J. Exp. Med. 177:547.
21. Bogdan, C., Y. Vodovotz, and C. Nathan. 1991. Macrophage deactivation by interleukin-10. J. Exp. Med. 174:1549.
22. Willems, F., A. Marchant, J. P. Delville, C. Gérard, A. Delvaux, T. Velu, M. de Boer, and M. Goldman. 1994. Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes. Eur. J. Immunol. 24:1007.
23. Brass, C. A., and T. G. Roberts. 1995. Hepatic free radical production after cold storage: Kupffer cell-dependent and -independent mechanisms in rats. Gastroenterology 108:1167.
24. Függer, R., G. Hamilton, R. Steininger, D. Mirza, F. Schulz, and F. Mülbacher. 1991. Intraoperative estimation of endotoxin, TNFα and IL-6 in orthotopic liver transplantation and their relation to rejection and postoperative infection. Transplantation 52:302.
25. Shen, L., P. M. Guyre, E. D. Ball, and M. W. Fanger. 1986. Glucocorticoid enhances interferon effects on human monocyte antigen expression and ADCC. Clin. Exp. Immunol. 65:387.
26. Schandené, L., C. Alonso-Vega, F. Willems, C. Gérald, A. Delvaux, T. Velu, R. Devos, M. de Boer, and M. Goldman. 1994. B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10. J. Immunol. 152:4368.
27. Wanidworanun, C., and W. Strober. 1993. Predominant role of tumor necrosis factor-α in human monocyte IL-10 synthesis. J. Immunol. 151:6853.
28. Paterson, A. R. P., E. Y. Lau, E. Dahlig, and C. E. Cass. 1980. A common basis for inhibition of nucleoside transport by dipyridamole and nitrobenzylthioinosine? Mol. Pharmacol. 18:40.
29. Cronstein, B. N. 1994. Adenosine, an endogenous anti-inflammatory agent. J. Appl. Physiol. 76:5.
30. Olsson, R. A., and J. D. Pearson. 1990. Cardiovascular purinoceptors. Physiol. Rev. 70:761.
31. Belzer, F. O., and J. H. Southard. 1988. Principles of solid-organ preservation by cold storage. Transplantation 45:673.
32. Le Moine, O., A. Marchant, F. Durand, B. Ickx, O. Pradier, J. Belghiti, D. Abramowicz, M. Gelin, M. Goldman, and J. Devière. 1994. Systemic release of interleukin-10 during orthotopic liver transplantation. Hepatology 20:889.
33. Cassatella, M. A., L. Meda, S. Bonora, M. Ceska, and G. Constantin. 1993. Interleukin-10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1β in mediating the production of IL-8 triggered by lipopolysaccharide. J. Exp. Med. 178:2207.
34. Salvatore, C. A., M. A. Jacobson, H. E. Taylor, J. Linden, and R. G. Johnson. 1993. Molecular cloning and characterization of the human A3 adenosine receptor. Proc. Natl. Acad. Sci. USA 90:10365.
35. Sajjadi, F. G., and G. S. Firenstein. 1993. cDNA cloning and sequence analysis of the human A3 adenosine receptor. Biochim. Biophys. Acta 1179:105.
36. Liu, G. S., S. C. Richards, R. A. Olsson, K. Mullane, R. S. Walsh, and J. M. Downey. 1994. Evidence that the adenosine A3 receptor may mediate the protection afforded by preconditioning in the isolated rabbit heart. Cardiovasc. Res. 28:1057.
37. Von Lubitz, D. K. J. E., R. C. S. Lin, P. Popik, M. F. Carter, and K. A. Jacobson. 1994. Adenosine A3 receptor stimulation and cerebral ischemia. Eur. J. Pharmacol. 263:59.
38. Ramkumar, V., M. Wilson, D. N. Dhanraj, T. W. Gettys, and H. Ali. 1995. Dexamethasone up-regulates A3 adenosine receptors in rat basophilic leukemia (RBL-2H3) cells. J. Immunol. 154:5436.
39. Antonysamy, M. A., E. J. Motika, and V. Ramkumar. 1995. Adenosine acts as an endogenous modulator of IL-2-dependent proliferation of cytotoxic T lymphocytes. J. Immunol. 155:2813.
40. Lin, W. H., K. A. Marcucci, R. A. Rabin, and J. A. Roth. 1991. 2-Chloroadenosine decreases tyrosylprotein sulfotransferase activity in the Golgi apparatus in PC12 cells. J. Biol. Chem. 266:14457.
41. Hoskin, D. W., T. Reynolds, and J. Blay. 1994. 2-Chloroadenosine inhibits the MHC-unrestricted cytolytic activity of anti-CD3-activated killer cells: evidence for the involvement of a non-A1/A2 cell surface adenosine receptor. Cell. Immunol. 159:85.
42. Londos, C., and J. Wolff. 1977. Two distinct adenosine-sensitive sites on adenylate cyclase. Proc. Natl. Acad. Sci. USA 74:5482.
43. Lad, P. M., T. B. Nielsen, C. Londos, M. S. Preston, and M. Rodbell. 1980. Independent mechanisms of adenosine activation and inhibition of the turkey erythrocyte adenylate cyclase system. J. Biol. Chem. 255:10841.
44. Marone, G., R. Petracca, S. Vigorita, and V. Casolaro, 1990. Adenosine receptors of human leukocytes-II: characterization of an inhibitory P-site. Biochem. Pharmacol. 40:1963.
45. Schreck, R., P. Rieber, and P. A. Baeuerle. 1991. Reactive oxygen intermediates as apparently widely used messengers in the activation of NF-κB transcription factor and HIV-1. EMBO J. 10:2247.
46. Los, M., W. Dröge, K. Stricker, P. A. Baeuerle, and K. Schulze-Osthoff. 1995. Hydrogen peroxide as a potent activator of T lymphocyte functions. Eur. J. Immunol. 25:159.
47. Lo, S. K., K. Janakidevi, L. Lai, and A. B. Malik. 1993. Hydrogen-peroxide induced increase in endothelial adhesiveness is dependent on ICAM-1 activation. Am. J. Physiol. 264:L406.
48. Müller, J. M., H. W. L. Ziegler-Heitbrock, and P. A. Baeuerle. 1993. Nuclear faclor κB, a mediator of lipopolysaccharide effects. Immunobiology 187:233.
49. Platzer, C., C. Meizel, K. Vogt, M. Platzer, and H. D. Volk. 1995. Up-regulation of monocytic IL-10 by tumor necrosis factor-alpha and cAMP elevating drugs. Int. Immunol. 7:517.
50. Strassmann, G., V. Patil-Koota, F. Finkelman, M. Fong, and T. Kambayashi. 1995. Evidence for the involvement of interleukin-10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2. J. Exp. Med. 180: 2365.
51. Arai, T., K. Hiromatsu, N. Kobayashi, M. Takano, H. Ishida, Y. Nimura, and Y. Yoshikai. 1995. IL-10 is involved in the protective effect of dibutyryl cyclic adenosine monophosphate on endotoxin-induced inflammatory liver injury. J. Immunol. 155:5743.
52. Kambayashi, T., C. O. Jacob, D. Zhou, N. Mazurek, M. Fong, and O. Strassmann. 1995. Cyclic nucleotide phosphodiesterase type IV participates in the regulation of IL-10 and in the subsequent inhibition of TNF-α and IL-6 release by endotoxin-stimulated macrophages. J. Immunol. 155:4909.